JBIO JADE BIOSCIENCES
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 10 analyst firms say about JADE BIOSCIENCES: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 6 months
Analyst view · last 6M
8 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #40 in the index87
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8056
Recent analyst activity · last 90 days
Our tracked history has 10 reports on JBIO from 7 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 4 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: BTIG Research raised its target from $74.00 (set 1 Jun 2026) to $77.00 on 10 Aug 2026.
Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Julian Harrison | Buy | 27 Oct 2026 | 77.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 3 Sep 2026 | 48.00 USD |
| Guggenheim | Vamil Divan | Buy | 2 Jun 2026 | 47.00 USD |
| H.C. Wainwright | Arthur He | Buy | 1 Oct 2026 | 55.00 USD |
| Jefferies | Akash Tewari | Buy | 21 May 2026 | 48.00 USD |
| Piper Sandler | Unnamed analyst | — | 2 Jun 2026 | 55.00 USD |
| UBS | Michael Yee | Buy | 15 Jun 2026 | 45.00 USD |
| Wedbush | Laura Chico | Buy | 1 Oct 2026 | 47.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Sep 2026 | — |
| William Blair | Matt Phipps | Buy | 10 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.